Celloré DHA 500
Natural health product licensed in Canada
- Licence holder
- Celavie Laboratoire Corporation
- NPN or DIN-HM
- 80146877
- Status
- Active licence
- Licence date
- 15 January 2026
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
(p)-hydroxybenzoate de méthyle, (p)-hydroxybenzoate de propyle, Mélange de concentré de tocophérols, Gélatine, Citrate de triéthyle, Copolymère d'acide méthacrylique, Glycérine, Hydroxyde d'ammonium, Palmitate d'ascorbyle, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce (blood) triglyceride(s)/triacylglycerol(s) (levels). Helps support/maintain (normal) heart/cardiovascular health. Helps support/maintain eye health/function. Helps support/maintain visual health/function. Source of an essential fatty acid for the maintenance of good health. Source of docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acid for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80146877
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.